Reed’s Reports First Quarter 2024 Results
Reed’s (OTCQX: REED) reported its Q1 2024 financial results, highlighting significant cost optimizations despite lower net sales. Net sales decreased to $9.6 million from $11.2 million in Q1 2023.
However, gross profit rose by 26% to $3.4 million, and gross margin increased by 1,140 basis points to 35.6%. Delivery and handling costs dropped by 29%, and selling, general, and administrative expenses were reduced by 19%. Operating loss improved to $0.6 million, and modified EBITDA loss improved to $0.4 million. The company reiterated its 2024 financial outlook, projecting net sales growth, gross margin expansion, and modified EBITDA profitability, with positive cash flow from operations expected for the full year.
- Gross profit increased by 26% to $3.4 million.
- Gross margin rose by 1,140 basis points to 35.6%.
- Delivery and handling costs dropped by 29% to $1.5 million.
- Selling, general, and administrative expenses were reduced by 19% to $2.6 million.
- Operating loss improved to $0.6 million from $2.6 million.
- Modified EBITDA loss improved to $0.4 million from $2.3 million.
- Reed’s reiterated its 2024 outlook, expecting net sales growth, gross margin expansion, and modified EBITDA profitability.
- Anticipates positive cash flow from operations for the full year.
- Net sales decreased from $11.2 million to $9.6 million.
- Cash used in operations was $2.4 million compared to cash flow from operations of $1.1 million in Q1 2023.
- The company had only $0.3 million in cash as of March 31, 2024.
- Total debt stood at $26.0 million, including $18.2 million from a convertible note and $7.8 million from a revolving line of credit.
Reiterates Full Year 2024 Financial Outlook
Management to Host Conference Call Today at 5:00 p.m. ET
NORWALK, Conn., May 14, 2024 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three months ended March 31, 2024.
Q1 2024 Financial Highlights (vs. Q1 2023):
- Net sales were
$9.6 million compared to$11.2 million . - Gross profit increased
26% to$3.4 million , with gross margin up 1,140 bps to35.6% . - Delivery and handling costs were reduced by
29% to$3.01 per case. - Selling, general and administrative expenses were reduced by
19% to$2.6 million . - Operating loss improved to
$0.6 million compared to$2.6 million . - Modified EBITDA loss improved to
$0.4 million compared to$2.3 million .
Management Commentary
“We continued to drive cost-cutting and optimization initiatives in the first quarter, reflected by our material improvements in gross margin, operating expenses and modified EBITDA,” said Norman E. Snyder, Jr., CEO of Reed’s. “As highlighted during our earnings call in March, Q1 sales were impacted by short orders reducing shipments. However, we exited the quarter with healthier inventory levels and have already seen a reduction in the rate of short orders, which we expect to decline further moving forward.
“Looking ahead, we are reiterating our 2024 financial outlook as we continue to expect net sales growth, gross margin expansion, and modified EBITDA profitability while generating positive cash flow from operations for the full year. We have multiple initiatives to drive growth as we improve order fulfillment rates, expand product authorizations, increase promotional activity, and launch new innovative products later this year. Between our improved inventory position, optimized cost structure, and new product initiatives, we are poised for a strong second quarter and year ahead.”
First Quarter 2024 Financial Results
During the first quarter of 2024, net sales were
Gross profit for the first quarter of 2024 increased
Delivery and handling costs were reduced by
Selling, general and administrative costs declined by
Operating loss during the first quarter of 2024 improved to
Modified EBITDA loss improved to
Liquidity and Cash Flow
For the first quarter of 2024, cash used in operations was
As of March 31, 2024, the Company had approximately
FY 2024 Financial Outlook
The Company continues to project net sales growth, gross margin expansion, and to achieve modified EBITDA profitability for the full year 2024. Reed’s also expects to generate positive cash flow from operations for the full year 2024.
Conference Call
The Company will conduct a conference call today, May 14, 2024, at 5:00 p.m. Eastern time to discuss its results for the three months ended March 31, 2024.
Reed’s management will host the conference call, followed by a question-and-answer period.
Date: Tuesday, May 14, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in number: (888) 886-7786
International dial-in number: (416) 764-8658
Conference ID: 71895807
Webcast: Reed’s Q1 2024 Conference Call
Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at (720) 330-2829.
The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://investor.reedsinc.com.
About Reed's, Inc.
Reed’s is an innovative company and category leader that provides the world with high quality, premium and naturally bold™ better-for-you beverages. Established in 1989, Reed's is a leader in craft beverages under the Reed’s®, Virgil’s® and Flying Cauldron® brand names. The Company’s beverages are now sold in over 45,000 stores nationwide.
Reed’s is known as America's #1 name in natural, ginger-based beverages. Crafted using real ginger and premium ingredients, Reed’s portfolio includes ginger beers, ginger ales, ready-to-drink ginger mules and hard ginger ales. The brand has recently successfully expanded into the zero-sugar segment with its proprietary, natural sweetener system.
Virgil's® is an award-winning line of craft sodas, made with the finest natural ingredients and without GMOs or artificial preservatives. The brand offers an array of great tasting, bold flavored sodas including Root Beer, Vanilla Cream, Black Cherry, Orange Cream, and more. These flavors are also available in six zero sugar varieties which are naturally sweetened and certified ketogenic.
Flying Cauldron® is a non-alcoholic butterscotch beer prized for its creamy vanilla and butterscotch flavors. Sought after by beverage aficionados, Flying Cauldron is made with natural ingredients and no artificial flavors, sweeteners, preservatives, gluten, caffeine, or GMOs.
For more information, visit drinkreeds.com, virgils.com and flyingcauldron.com. To receive exclusive perks for Reed’s investors, please visit the Company’s page on the Stockperks app here.
Forward-Looking Statements
Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are typically identified by terms such as "estimate," "expect,” “intend,” "project," "will," “plan,” and similar expressions. These forward-looking statements are based on current expectations and include our management’s expectations and guidance for fiscal year 2024 under the heading “FY 2024 Financial Outlook”. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties, and assumptions, many of which involve factors or circumstances that are beyond our control. Reed‘s 2024 guidance reflects year-to-date and expected future business trends and includes impacts of the inventory shortage as of the date hereof. New supply chain challenges that may develop and further potential inflation cannot be reasonably estimated and are not factored into current fiscal 2024 guidance. These risks could materially impact our ability to access raw materials, production, transportation and/or other logistics needs.
Financial guidance should not be viewed as a substitute for full financial statements prepared in accordance with GAAP.
If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, Reed’s actual results could differ materially from the results expressed or implied by the forward-looking statements we make, including our ability to achieve our targets for the fiscal year ending December 31, 2024. The risks and uncertainties referred to above include, but are not limited to: inventory shortages; risks associated with new product releases; the impacts of further inflation; risks that customer demand may fluctuate or decrease; risks that we are unable to collect unbilled contractual commitments, particularly in the current economic environment; our ability to compete successfully and manage growth; our significant debt obligations; our ability to develop and expand strategic and third party distribution channels; our dependence on third party suppliers, brewers and distributors; third party co-packers meeting contractual commitments; risks related to our international operations; our ability to continue to innovate; our strategy of making investments in sales to drive growth; increasing costs of fuel and freight, protection of intellectual property; competition; general political or destabilizing events, including the wars in Ukraine and Israel, conflict or acts of terrorism; financial markets, commodity and currency impacts of the wars; the effect of evolving domestic and foreign government regulations, including those addressing data privacy and cross-border data transfers; and other risks detailed from time to time in Reed’s public filings, including Reed’s annual report on Form 10-K filed on April 1, 2024, which is available on the Securities and Exchange Commission’s web site at www.sec.gov. These forward-looking statements are based on current expectations and speak only as of the date hereof. Reed’s assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Investor Relations Contact
Sean Mansouri, CFA
Elevate IR
ir@reedsinc.com
(720) 330-2829
| REED’S, INC. | ||||||||
| CONDENSED STATEMENTS OF OPERATIONS | ||||||||
| For the Three Months Ended March 31, 2024 and 2023 | ||||||||
| (Unaudited) | ||||||||
| (Amounts in thousands, except share and per share amounts) | ||||||||
| March 31, | March 31, | |||||||
| 2024 | 2023 | |||||||
| Net Sales | $ | 9,595 | $ | 11,157 | ||||
| Cost of goods sold | 6,182 | 8,459 | ||||||
| Gross profit | 3,413 | 2,698 | ||||||
| Operating expenses: | ||||||||
| Delivery and handling expense | 1,502 | 2,120 | ||||||
| Selling and marketing expense | 1,093 | 1,447 | ||||||
| General and administrative expense | 1,468 | 1,709 | ||||||
| Total operating expenses | 4,063 | 5,276 | ||||||
| Loss from operations | (650 | ) | (2,578 | ) | ||||
| Interest expense | (1,023 | ) | (1,779 | ) | ||||
| Net loss | $ | (1,673 | ) | $ | (4,357 | ) | ||
| Net loss per share – basic and diluted | $ | (0.40 | ) | $ | (1.70 | ) | ||
| Weighted average number of shares outstanding – basic and diluted | 4,187,291 | 2,559,855 | ||||||
| REED’S, INC, | ||||||||
| CONDENSED BALANCE SHEETS | ||||||||
| (Amounts in thousands, except share amounts) | ||||||||
| March 31, | December 31, | |||||||
| 2024 | 2023 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | 314 | $ | 603 | ||||
| Accounts receivable, net of allowance of | 3,251 | 3,571 | ||||||
| Inventory | 12,017 | 11,300 | ||||||
| Receivable from former related party | 264 | 259 | ||||||
| Prepaid expenses and other current assets | 2,332 | 2,028 | ||||||
| Total current assets | 18,178 | 17,761 | ||||||
| Property and equipment, net of accumulated depreciation of | 441 | 493 | ||||||
| Intangible assets | 631 | 629 | ||||||
| Total assets | $ | 19,250 | $ | 18,883 | ||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 8,484 | $ | 9,133 | ||||
| Accrued expenses | 872 | 1,096 | ||||||
| Revolving line of credit, net of capitalized financing costs of | 7,844 | 9,758 | ||||||
| Payable to former related party | 331 | 259 | ||||||
| Current portion of convertible notes payable, net of debt discount of | 7,339 | 6,737 | ||||||
| Current portion of lease liabilities | 155 | 207 | ||||||
| Total current liabilities | 25,025 | 27,190 | ||||||
| SAFE agreements | 4,097 | - | ||||||
| Convertible note payable, net of debt discount of | 10,853 | 10,874 | ||||||
| Total liabilities | 39,975 | 38,064 | ||||||
| Stockholders’ deficit: | ||||||||
| Series A Convertible Preferred stock, | 94 | 94 | ||||||
| Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively | - | - | ||||||
| Additional paid in capital | 119,581 | 119,452 | ||||||
| Accumulated deficit | (140,400 | ) | (138,727 | ) | ||||
| Total stockholders’ deficit | (20,725 | ) | (19,181 | ) | ||||
| Total liabilities and stockholders’ deficit | $ | 19,250 | $ | 18,883 | ||||
| CONDENSED STATEMENTS OF CASH FLOWS | ||||||||
| For the Three Months Ended March 31, 2024 and 2023 | ||||||||
| (Unaudited) | ||||||||
| (Amounts in thousands) | ||||||||
| March 31, | March 31, | |||||||
| 2024 | 2023 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (1,673 | ) | $ | (4,357 | ) | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||
| Depreciation | 29 | 47 | ||||||
| Amortization of debt discount | 144 | 281 | ||||||
| Fair value of vested options | 129 | 229 | ||||||
| Fair value of vested restricted shares granted to officers | - | 4 | ||||||
| Change in allowance for doubtful accounts | (601 | ) | (39 | ) | ||||
| Inventory write-downs | (783 | ) | (228 | ) | ||||
| Accrued interest | 564 | 1,113 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 922 | 1,044 | ||||||
| Inventory | 66 | 1,102 | ||||||
| Prepaid expenses and other assets | (1,305 | ) | 338 | |||||
| Decrease in right of use assets | 39 | 32 | ||||||
| Accounts payable | 351 | 1,360 | ||||||
| Accrued expenses | (225 | ) | 235 | |||||
| Lease liabilities | (52 | ) | (44 | ) | ||||
| Net cash provided by (used in) operating activities | (2,395 | ) | 1,117 | |||||
| Cash flows from investing activities: | ||||||||
| Trademark costs | (2 | ) | - | |||||
| Purchase of property and equipment | (16 | ) | - | |||||
| Net cash used in investing activities | (18 | ) | - | |||||
| Cash flows from financing activities: | ||||||||
| Proceeds from line of credit | 8,285 | 8,699 | ||||||
| Payments on line of credit | (10,239 | ) | (12,120 | ) | ||||
| Proceeds from convertible note payable, net of expenses | - | 2,405 | ||||||
| Proceeds from SAFE agreement | 4,097 | - | ||||||
| Payment of cost recorded as debt discount | (86 | ) | ||||||
| Repurchase of common stock | - | (1 | ) | |||||
| Amounts from former related party, net | 67 | (166 | ) | |||||
| Net cash provided by (used in) financing activities | 2,124 | (1,183 | ) | |||||
| Net increase (decrease) in cash | (289 | ) | (66 | ) | ||||
| Cash at beginning of period | 603 | 533 | ||||||
| Cash at end of period | $ | 314 | $ | 467 | ||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for interest | $ | 318 | $ | 390 | ||||
| Non-cash investing and financing activities: | ||||||||
| Reclass of prepaid expenses and accounts payable | $ | 1,000 | $ | 0 | ||||
Modified EBITDA
In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, tax expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, legal and insurance settlements, inventory write-offs associated with exited categories and major packaging and formula changes, one-time changes to policy for discounts, impact of changes to accounting methodology and one-time restructuring-related costs including employee severance and asset impairment.
Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended March 31, 2024, and 2023 (unaudited; in thousands):
| Three Months Ended | ||||||||
| March 31 | ||||||||
| 2024 | 2023 | |||||||
| Net loss | $ | (1,673 | ) | $ | (4,357 | ) | ||
| Modified EBITDA adjustments: | ||||||||
| Depreciation and amortization | 68 | 80 | ||||||
| Tax expense | 54 | |||||||
| Interest expense | 1,023 | 1,779 | ||||||
| Product quality hold write-down | 29 | |||||||
| Stock option and other noncash compensation | 129 | 233 | ||||||
| Total EBITDA adjustments | $ | 1,303 | $ | 2,092 | ||||
| Modified EBITDA | $ | (370 | ) | $ | (2,265 | ) | ||
We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:
- Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
- Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
- Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.
FAQ
What were Reed’s Q1 2024 net sales?
How did Reed’s gross profit perform in Q1 2024?
What was Reed’s Q1 2024 gross margin?
How much did Reed’s reduce its delivery and handling costs in Q1 2024?
What was Reed’s operating loss in Q1 2024?
What was Reed’s modified EBITDA loss in Q1 2024?
What is Reed’s financial outlook for 2024?
